Scopus Publication Detail
The publication detail shows the title, authors (with indicators showing other profiled authors), information on the publishing organization, abstract and a link to the article in Scopus. This abstract is what is used to create the fingerprint of the publication.
Clinical Pharmacology and Therapeutics. 2008;83(5):702-710.Abstract
Tamoxifen induces important changes in serum lipid profiles in some women; however, little information is available to predict which women will experience improved lipid profiles during tamoxifen therapy. As part of a multicenter prospective observational trial in 176 breast cancer patients, we tested the hypothesis that tamoxifen-induced lipid changes were associated with genetic variants in candidate target genes (CYP2D6, ESR1, and ESR2). Tamoxifen lowered low-density lipoprotein cholesterol (P<0.0001) by 23.5 mg/dl (13.5-33.5 mg/dl) and increased triglycerides (P=0.006). In postmenopausal women, the ESR1-XbaI and ESR2-02 genotypes were associated with tamoxifen-induced changes in total cholesterol (P=0.03; GG vs GA/AA) and triglycerides (P=0.01; gene-dose effect), respectively. In premenopausal women, the ESR1-XbaI genotypes were associated with tamoxifen-induced changes in triglycerides (P=0.002; gene-dose effect) and high-density lipoprotein (P=0.004; gene-dose effect). Our results suggest that estrogen receptor genotyping may be useful in predicting which women would benefit more from tamoxifen. © 2007 American Society for Clinical Pharmacology and Therapeutics.
PMID: 17713466 PMCID: PMC2782693
This section shows information related to the publication - computed using the fingerprint of the publication - including related publications, related experts with fingerprints representing significant amounts of overlap between their fingerprint and this publication. The red dots indicate whether those experts or terms appear within the publication, thereby showing potential and actual connections.
D.F. Hayes; T.C. Skaar; J.M. Rae; N.L. Henry; A.T. Nguyen; V. Stearns; L. Li; S. Philips; Z. Desta; D.A. FlockhartClinical Pharmacology and Therapeutics. 2010;88(5):626-629.
N.L. Henry; A. Nguyen; F. Azzouz; L. Li; J. Robarge; S. Philips; D. Cao; T.C. Skaar; J.M. Rae; A.M. Storniolo; et al.British Journal of Cancer. 2010;102(2):294-300.
Sunil Badve; Nikail R. Collins; Poornima Bhat-Nakshatri; Dmitry Turbin; Samuel Leung; Mangesh Thorat; Sandra E. Dunn; Tim R. Geistlinger; Jason S. Carroll; et al.American Journal of Pathology. 2010;176(5):2139-2149.
Appears in this Document